Subjects
Thirty blood samples of laboratory-confirmed pandemic 2009 H1N1 IAV-infected patients were provided from the Jeonbuk National University Hospital Biobank, a member of the Korea Biobank Network. A total of 204 blood samples from healthy Korean subjects were obtained from the Korea Biobank Network at the Centers for Disease Control and Prevention. All samples derived from the Korea Biobank Network were obtained with informed consent under institutional review board-approved protocols. The exclusion criteria of healthy Koreans included diabetes, high blood pressure, gastritis, gastric ulcer, myocardial infarction, thyroid disease, congestive heart failure, coronary artery disease, hypothyroidism asthma, chronic lung disease, peripheral vascular disease, kidney disease, hepatitis, tuberculosis, cerebrovascular disease, head trauma, urinary tract infection, arthritis and cancer. All the samples and related data were anonymized prior to the analysis.
Genomic DNA extraction
Genomic DNA was extracted from 200 μl of blood using the Blood Genomic DNA Isolation Kit (Qiagen, Valencia, California, USA) following the manufacturer’s instructions.
Amplification of the IFITM3 gene and genetic analysis
The human IFITM3 gene was amplified from genomic DNA using forward and reverse gene-specific primers. The sequences of the primers were as follows: IFITM3-F (5′-CAGGGGAAGTCTCCAGGACC-3′) and IFITM3-R (5′-CCAAGCCACACACACACACA-3′). Polymerase chain reaction (PCR) was performed using GoTaq® DNA Polymerase (Promega, Fitchburg, Wisconsin, USA). The PCR mixture contained 20 pmol of each primer, 5 μl of 10 × Taq DNA polymerase buffer, 1 μl of 10 mM dNTP mixture and 2.5 units of Taq DNA polymerase.
The PCR conditions of IFITM3-F and IFITM3-R primers were 94 °C for 2 min to denature; 35 cycles of 94 °C for 45 s, 71 °C for 45 s, and 72 °C for 1 min 30 s; and then 1 cycle of 72 °C for 10 min to extend the reaction. PCR was performed using S-1000 Thermal Cycler (Bio-Rad, Hercules, California, USA). The PCR products were purified using the PCR Purification Kit (Thermo Fisher Scientific, Bridgewater, New Jersey, USA) and directly sequenced with an ABI 3730 Automated Sequencer (ABI, Foster City, California, USA). Sequencing results were read by Finch TV software (Geospiza Inc, Seattle, Washington, USA), and genotyping was carried out.
Literature search
A literature search was conducted to looking for rs12252 SNP of the IFITM3 gene in previous studies. The searching terms were: “IFITM3”, “SNP”, “IAV” combined with “pandemic” or “susceptibility”. Moreover, we supplemented our search by screening the reference lists of the relevant studies, including the original article. References for all identified publications were indicated in Table 2.
Genetic analysis
Statistical analyses were performed using SAS version 9.4 (SAS Institute Inc., USA). The differences in genotype and allele frequencies of the IFITM3 gene between case and control populations compared using χ2 test. The Hardy–Weinberg Equilibrium (HWE) test was performed using HWE calculator (https://www.genes.org.uk/software/hardy-weinberg.shtml).